Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population☆
References (64)
The degree of masculine differentiation of obesities: A factor determining predisposition to diabetes, atherosclerosis, gout and uric calculous disease
Am J Clin Nutr
(1956)- et al.
Central adiposity and increased risk of coronary artery disease mortality in older women
Ann Epidemiol
(1993) - et al.
Plasma insulin after myocardial infarction
Lancet
(1965) - et al.
Reappraisal of the role of insulin in hypertriglyceridemia
Am J Med
(1974) - et al.
Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: Stronger associations in lean versus obese subjects
Metabolism
(1995) Cardiovascular actions of insulin in humans
- et al.
Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia
Am Heart J
(1993) - et al.
Associations of body fat and its distribution with dietary intake, physical activity, alcohol, and smoking in blacks and whites
Am J Clin Nutr
(1992) - et al.
Correlates of body fat distribution—Variation across categories of race, sex and body mass in the Atherosclerosis Risk in Communities Study
Ann Epidemiol
(1995) - et al.
Hyperinsulinaemia: A key feature of a cardiovascular and metabolic syndrome
Diabetologia
(1991)
Prospective analysis of the insulin-resistance syndrome (syndrome X)
Diabetes
(1992)
Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome?
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913
Br Med J
(1984)
Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden
Br Med J
(1984)
The associations between obesity, adipose tissue distribution and disease
Acta Med Scand
(1988)
Relation of body fatness and its distribution to cardiovascular risk factors in young blacks and whites
Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a twenty-three year follow-up study
Int J Obes
(1992)
Body fat distribution and 5-year risk of death in older women
JAMA
(1993)
The deadly quartet—Upper body obesity, glucose intolerance, hypertriglyceridemia and hypertension
Arch Intern Med
(1989)
“Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
Arteriosclerosis
(1990)
Insulin resistance in visceral obesity
Int J Obes
(1991)
Plasma insulin in coronary heart disease
Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration
Diabetes Care
(1979)
Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland
Diabetes Care
(1979)
Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
Diabetologia
(1980)
Plasma insulin and lipoprotein concentrations: An atherogenic association?
Am J Epidemiol
(1983)
Hyperinsulinemia—A link between hypertension, obesity and glucose intolerance
J Clin Invest
(1985)
Apolipoprotein, low-density lipoprotein subfraction and insulin associations with familial combined hyperlipidemia: Study of Utah patients with familial dyslipidemic hypertension
Arteriosclerosis
(1989)
Elevated serum uric acid—A facet of hyperinsulinemia
Diabetologia
(1987)
Banting Lecture 1988: Role of insulin resistance in human disease
Diabetes
(1988)
Insulin resistance—A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and other atherosclerotic cardiovascular disease
Diabetes Care
(1991)
Relation of components of insulin resistance syndrome to coronary disease risk
Curr Opin Lipidol
(1994)
Cited by (0)
- ☆
Supported by National Heart, Lung, and Blood Institute Contracts No. N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022, and in part by a fellowship from the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Technológico (M.I.S.), a fellowship from the Brazilian Ministry of Education (B.B.D.), an Overseas Research Fellowship from the Health Research Council of New Zealand (P.M.), and a Career Development Award from the American Diabetes Association (F.L.B.).
Copyright © 1996 Published by Elsevier Inc.